Search results for PX-TA1289
Showing 1 – 10 of1products

ID: BAB429118506
Demcizumab Biosimilar – Anti-DLL4 mAb – Research Grade, ProteoGenix, PX-TA1289
Description of Demcizumab Biosimilar - Anti-DLL4 mAb - Research Grade General information on Anti-DLL4 [Homo sapiens] (Demcizumab) Monoclonal Antibody Demcizumab is investigated for the treatment of Nonsquamous Nonsmall Cell Neoplasm of Lung.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
